AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

OPKO Health Inc.

Major Shareholding Notification May 10, 2022

6963_rns_2022-05-10_062dc200-4864-40a6-9182-180513c19e9e.pdf

Major Shareholding Notification

Open in Viewer

Opens in native device viewer

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

OMB APPROVAL

OMB Number: 3235-0104
Estimated average burden hours
per response 0.5

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person
OPKO Health, Inc.
2. Date of Event Requiring
Statement (Month/Day/Year)
3. Issuer Name and Ticker or Trading Symbol
Sema4 Holdings, Corp. [SMFR]
(Last)
4400 Biscayne Blvd.
(First) (Middle) 04/29/2022 4. Relationship of Reporting Person(s) to
5. If Amendment, Date Original
Issuer
Filed(Month/Day/Year)
(Check all applicable)
(Street)
Miami
FL 33137 _ Director
6. Individual or Joint/Group Filing (Check
X 10% Owner
_ Officer (give title
____ Other (specify
Applicable Line)
below)
below)
X
Form filed by One Reporting Person
(City) (State) (Zip) ____ Form filed by More than One
Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
Owned
(Instr. 4)
2. Amount of Securities Beneficially
3. Ownership
4. Nature of Indirect Beneficial Ownership
Form: Direct (D)
(Instr. 5)
or Indirect (I)
(Instr. 5)

Class A Common Stock, par value \$0.0001 per share 80,000,000 D

Table II - Derivative Securities Beneficially Owned ( e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security
(Instr. 4)
2. Date Exercisable and
Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities
Underlying Derivative Security
(Instr. 4)
4. Conversion or
Exercise Price of
Derivative
5. Ownership
Form of
Derivative
6. Nature of Indirect Beneficial
Ownership
(Instr. 5)
Date
Exercisable
Expiration
Date
Title Amount or Number of
Shares
Security Security: Direct
(D) or Indirect (I)
(Instr. 5)

Explanation of Responses:

/s/Steven D. Rubin, authorized signatory 05/09/2022

**Signature of Reporting Person Date

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.

Talk to a Data Expert

Have a question? We'll get back to you promptly.